Replacement: Total Voting Rights
Updated : 07:01
24 April 2024
Idox plc
("Idox" or "Group" or "Company")
Correction - Exercise of Share Options and Total Voting Rights
The following amendment has been made to the "Exercise of Share Options & Total Voting Rights" announcement released 17 April 2024 at 12.43pm under RNS No. 0060L
The original announcement incorrectly stated that the figure to be used for both the total number of ordinary shares in issue following Admission and the total number of ordinary shares with voting rights in the Company was 457,771,879. The correct figure to be used for the total number of ordinary shares in issue following Admission will be 459,377,981. The correct figure to be used for the total number of ordinary shares with voting rights in the Company will be 459,377,981.
All other details remain unchanged. The full amended text is shown below.
Idox plc (AIM: IDOX) a leading supplier of specialist information management software and geospatial data solutions to the public and asset-intensive sectors, announces that it has issued 77,000 new ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to an exercise of options by employees under its Idox plc Long Term Incentive Plans.
An application has been made for the 77,000 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 22 April 2024.
The Company holds no ordinary shares in treasury. The total number of ordinary shares in issue following Admission will be 459,377,981. Therefore, the total number of ordinary shares with voting rights in the Company will be 459,377,981.
The above figure of 459,377,981 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
-Ends-
For further information please contact:
Idox plc | +44 (0) 870 333 7101 |
Chris Stone, Non-Executive Chairman | investorrelations@idoxgroup.com |
David Meaden, Chief Executive |
|
Anoop Kang, Chief Financial Officer |
|
| |
Peel Hunt LLP (NOMAD and Broker) | +44 (0) 20 7418 8900 |
Paul Gillam |
|
Adam Telling |
|
| |
MHP | + 44 (0) 20 3128 8100 |
Reg Hoare | |
Ollie Hoare | |
Matthew Taylor |
About Idox plc
For more information see www.idoxplc.com @Idoxgroup
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.